FDA Drug Application (020326) for NEUTREXIN by MEDIMMUNE ONCOLOGY

Back to FDA Applications sponsored by MEDIMMUNE ONCOLOGY

Application Number020326
Product Number001
FormINJECTABLE;INJECTION
DosageEQ 25MG BASE/VIAL
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNEUTREXIN
Active IngredientTRIMETREXATE GLUCURONATE



Back to FDA Applications sponsored by MEDIMMUNE ONCOLOGY